000			01904 a2200541 4500
005			20250516015030.0
264		0	_c20110516
008			201105s 0 0 eng d
022			_a1873-5576
024	7		_a10.2174/156800911794328501 _2doi
040			_aNLM _beng _cNLM
100	1		_aMontopoli, M
245	0	0	_a"Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. _h[electronic resource]
260			_bCurrent cancer drug targets _cFeb 2011
300			_a226-35 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xmetabolism
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCisplatin _xmetabolism
650	0	4	_aCytoplasmic Granules _xdrug effects
650	0	4	_aDNA, Mitochondrial _xgenetics
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGlucose _xmetabolism
650	0	4	_aGlutathione _xmetabolism
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aLipid Metabolism _xdrug effects
650	0	4	_aMembrane Potential, Mitochondrial _xdrug effects
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aOligomycins _xpharmacology
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aOxidative Phosphorylation _xdrug effects
650	0	4	_aOxygen Consumption _xdrug effects
650	0	4	_aRotenone _xpharmacology
650	0	4	_aUncoupling Agents _xpharmacology
700	1		_aBellanda, M
700	1		_aLonardoni, F
700	1		_aRagazzi, E
700	1		_aDorigo, P
700	1		_aFroldi, G
700	1		_aMammi, S
700	1		_aCaparrotta, L
773	0		_tCurrent cancer drug targets _gvol. 11 _gno. 2 _gp. 226-35
856	4	0	_uhttps://doi.org/10.2174/156800911794328501 _zAvailable from publisher's website
999			_c20447960 _d20447960